Comparing the oral cancer surgery group (G1) with patients receiving minor maxillofacial surgery (G3), a significantly lower FOXP3 expression could be detected directly postoperatively as well as on day 2. The gene discussed is FOXP3; the disease is lip and oral cavity carcinoma.